Where does Torrey Pines Institute for Molecular Studies rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Torrey Pines Institute for Molecular Studies ranks #18,210 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Torrey Pines Institute for Molecular Studies hold?

Torrey Pines Institute for Molecular Studies holds 16 US utility patents granted between 2016 and 2024, spanning 11 technology areas.

What is Torrey Pines Institute for Molecular Studies's Innovation Score?

Torrey Pines Institute for Molecular Studies has an Innovation Score of 34.2 out of 100 (47th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Torrey Pines Institute for Molecular Studies focus on?

Torrey Pines Institute for Molecular Studies's top technology area is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes) with 12 patents, ranking #1,877 of 7,163 assignees active in that subclass. Grants appear in 11 CPC subclasses total.

Is Torrey Pines Institute for Molecular Studies's patent grant rate increasing or decreasing?

Torrey Pines Institute for Molecular Studies's recent grant velocity is -40% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Torrey Pines Institute for Molecular Studies's patents?

Torrey Pines Institute for Molecular Studies's patents average 16.7 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

USPTO 2015–2025 USPTO PatentsView US Corporation

Torrey Pines Institute for Molecular Studies

Q: How is the Torrey Pines Institute for Molecular Studies patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO PatentsView assignee record - 16 granted patents across 11 technology areas, recorded in grant years 2016–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (Preparations FOR Medical, Dental OR Toiletry Purposes).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Torrey ranks #18,210 of 49,997 tracked US assignees by granted-patent volume, with 16 patents across 11 technology areas.

#18,210
of 49,997 US assignees by volume: 47th percentile
by Innovation Score (34.2/100): 16.7
avg claims per patent: -40%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R18210 · US Corporation #18,210 · 16 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-DOWN · BOOK-FULL

GRANTS-MICRO 16 grants
MID-PACK #18,210/49,997
PHOTO-FINISH Tolmar Therapeutics
CPC-FOCUS A61K · 11 areas
INNOV-THIN 34.2/100
CLAIMS-RICH 16.7 claims/avg
TYPE-USCORP US Corporation
VEL-DOWN -40% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Tolmar Therapeutics, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Torrey’s 34.2 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 9.8 pts (29%) Velocity 2.7 pts (8%) Breadth 11.7 pts (34%) Claim depth 10.0 pts (29%)

Qualcomm Incorporated · highest

85
Torrey Pines… · this assignee

34
3D Lighting… · lowest

7

What this shows Torrey's Innovation Score is 34.2/100 (47th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Torrey?

Each dot is one of Torrey’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Torrey’s own 16.7 claims/patent is ABOVE the 13.1 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Torrey vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Torrey's grants concentrate

Torrey Pines Institute for Molecular Studies is a focused PatentsView assignee: 11 CPC subclasses with 75% of grants classified under A61K (Preparations FOR Medical, Dental OR Toiletry Purposes). Peak complete grant year is 2018 (5 grants) versus a trough of 1 in 2019. By volume, Torrey sits between Tolmar Therapeutics, Inc. and TriLite Technologies GmbH.

Torrey's three-year grant acceleration

Torrey Pines Institute for Molecular Studies shows 2 grants in 2022–2024 against only 5 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Tolmar Therapeuti…

16
Top Glory Trading…

16
Topia Technology

16
Torrent Pharmaceu…

16
Torshare

16
Total E&P Danmark…

16
Translatum Medicus

16
Trilite

16
Torrey Pines Inst… ◀

16

What this shows Torrey holds 16 patents at rank #18,220, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Torrey

By rank, the assignees closest to #18,220 in granted patent volume.

Leaders in A61K (Preparations FOR Medical)

Other assignees with the most granted patents in Torrey's primary technology class.

Torrey's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

34 47th percentile higher than 47% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2016–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table

Torrey Pines Institute for Molecular Studies patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2016	2	12.5%
2017	2	12.5%
2018	5	31.3%
2019	1	6.3%
2020	1	6.3%
2021	3	18.8%
2022	1	6.3%
2024	1	6.3%

Which technologies does Torrey Pines Institute for Molecular Studies patent most?

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 12

C07D - Heterocyclic Compounds 12

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 9

C07C - Acyclic OR Carbocyclic Compounds 7

C07K - Peptides 6

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 3

C07B - General Methods OF Organic CHEMISTRY; Apparatus Therefor 2

A01N - Preservation OF Bodies OF Humans OR Animals OR Plants OR Parts Thereof ; Biocides, e.g. AS Disinfectants, AS Pesticides OR AS Herbicides ; Pest Repellants OR ATTRACTANTS; Plant Growth Regulators 2

G16B - Bioinformatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR Genetic OR Protein-related Data Processing IN Computational Molecular Biology 2

B01J - Chemical OR Physical Processes, e.g. Catalysis OR Colloid CHEMISTRY; Their Relevant Apparatus 2

G16C - Computational CHEMISTRY; CHEMOINFORMATICS; Computational Materials Science 2

Top 11 of 11 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Torrey Pines Institute for Molecular Studies's patent record in context - here's where to go next.

Torrey Pines Institute for Molecular Studies's lead technology class is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes), 75% of its portfolio - see every assignee active in that class. Explore A61K
Ranked #18,210 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Torrey Pines Institute for Molecular Studies against Tolmar Therapeutics, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 34.2/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.